PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-43

  1. 14,651 Posts.
    lightbulb Created with Sketch. 1583
    https://m.youtube.com/watch?v=90L3xNXKye0

    Sam
    Watch the video
    At the 22.51 mark JG explains that if the read out is positive
    the Commercial reality is that a Partner will do all the leg work re distribution etc

    then you ask the Question
    28.53
    you say that the staff is 90% clinicians / Scientists
    where is the financial know how ?
    Like JG said
    we are a Drug Development Coy
    in other words.. the pathway for PER is moving towards drug development and not day to day selling of our drugs ..
    Most here understand where you were coming from..
    I know you better than most.. your ill feelings towards the last Board and now the new Board expressed by the unwashed group …





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $5.737K 573.7K

Buyers (Bids)

No. Vol. Price($)
1 3633138 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3174000 4
View Market Depth
Last trade - 15.22pm 17/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.